Tomocube Inc
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to a… Read more
Tomocube Inc (475960) - Total Liabilities
Latest total liabilities as of September 2025: ₩3.43 Billion KRW
Based on the latest financial reports, Tomocube Inc (475960) has total liabilities worth ₩3.43 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tomocube Inc - Total Liabilities Trend (2021–2024)
This chart illustrates how Tomocube Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tomocube Inc Competitors by Total Liabilities
The table below lists competitors of Tomocube Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hoasen Group
VN:HSG
|
Vietnam | ₫9.68 Trillion |
|
The India Cements Limited
NSE:INDIACEM
|
India | ₹35.90 Billion |
|
PARATUS ENERGY SERVICES LTD
OL:PLSV
|
Norway | Nkr448.86 Million |
|
China National Complete Plant Import & Export Corp Ltd
SHE:000151
|
China | CN¥1.97 Billion |
|
Royal Group Co Ltd
SHE:002329
|
China | CN¥3.64 Billion |
|
Anhui Sunhere Pharmaceutical Excipients Co Ltd
SHE:300452
|
China | CN¥592.53 Million |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥165.15 Million |
|
One United Properties SA
RO:ONE
|
Romania | RON2.35 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Tomocube Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 15.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tomocube Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tomocube Inc (2021–2024)
The table below shows the annual total liabilities of Tomocube Inc from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.62 Billion | -21.61% |
| 2023-12-31 | ₩2.07 Billion | -96.09% |
| 2022-12-31 | ₩52.89 Billion | -40.06% |
| 2021-12-31 | ₩88.24 Billion | -- |